Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal
Patent
1981-06-03
1982-11-16
Lieberman, Allan
Chemistry of carbon compounds
Miscellaneous organic carbon compounds
C-metal
424 99, 424177, C07G 700
Patent
active
043594158
ABSTRACT:
The passage of human urine through a bed of adsorbent material results in the adsorption from the urine of antineoplastic substances as determined by in vitro tissue culture techniques utilizing human tumor cells. The adsorbent yields two antineoplastic fractions upon sequential elution. Elution of the low-molecular weight antineoplastic fraction is accomplished by elution with cold aqueous acetone at slightly alkaline pH. Thereafter, elution of the high molecular weight antineoplastic fraction is accomplished by elution with a cold aqueous acetone-glycerol mixture at slightly alkaline pH.
The antineoplastic activities of these fractions are determined by tissue culture techniques employing a variety of human neoplastic cells. Furthermore, the high molecular weight fraction, the antineoplastic urinary protein, also inhibits the progression and causes regression of certain human tumor cells implanted in the nude mouse.
REFERENCES:
patent: 3711377 (1973-11-01), Sloane
Chem Abs. 71:20387a.
Burzynski Physiol. Chem. & Physics pp. 457-468, 6(1974).
Burzynski et al. Physiol. Chem. & Physics pp. 13-22, 8(1976).
Burzynski Physiol. Chem. & Physics pp. 275-279, 8(1976).
Burzynski Physiol. Chem. & Physics pp. 437-447, 5(1973).
Lieberman Allan
Short P.
University of Tennessee Research Corporation
LandOfFree
Isolation of an antineoplastic protein fraction and an antineopl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation of an antineoplastic protein fraction and an antineopl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of an antineoplastic protein fraction and an antineopl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1435551